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Abstract
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The molecular basis of Fructose-2,6-bisphosphatase (F-2,6-P2ase) of 6-phosphofructo-2-kinase/
fructose-2,6-bisphosphatase (PFKFB) was investigated using the crystal structures of the human
inducible form (PFKFB3) in a phospho-enzyme intermediate state (PFKFB3-P•F-6-P), in a
transition state-analogous complex (PFKFB3•AlF4), and in a complex with pyrophosphate
(PFKFB3•PPi) at resolutions of 2.45Å, 2.2Å, and 2.3Å, respectively. Trapping the PFKFB3P•F-6-P intermediate was achieved by flash cooling the crystal during the reaction, and the
PFKFB3•AlF4 and PFKFB3•PPi complexes were obtained by soaking. The PFKFB3•AlF4 and
PFKFB3•PPi complexes resulted in removing F-6-P from the catalytic pocket. With these
structures, the structures of the Michaelis complex and the transition state were extrapolated. For
both the PFKFB3-P formation and break down, the phosphoryl donor and the acceptor are located
within ~5.1Å, and the pivotal point 2-P is on the same line, suggesting an “in-line” transfer with a
direct inversion of phosphate configuration. The geometry suggests that NE2 of His253 undergoes
a nucleophilic attack to form a covalent N-P bond, breaking the 2O-P bond in the substrate. The
resulting high reactivity of the leaving group, 2O of F-6-P, is neutralized by a proton donated by
Glu322. Negative charges on the equatorial oxygens of the transient bipyramidal phosphorane
formed during the transfer are stabilized by Arg252, His387, and Asn259. The C-terminal domain
(residues 440–446) was rearranged in PFKFB3•PPi, implying that this domain plays a critical role
in binding of substrate to and release of product from the F-2,6-P2ase catalytic pocket. These
findings provide a new insight into the understanding of the phosphoryl transfer reaction.
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Introduction
Fructose-2,6-bisphosphate (F-2,6-P2) is known to be the most potent allosteric activator of
the rate-limiting enzyme in glycolysis, 6-phosphofructose-1-kinase (PFK-1), as well as an
inhibitor of the gluconeogenic enzyme fructose-1,6-bisphosphatase (F-1,6-P2ase). As such,
this small signaling molecule allows for switching between the two pathways of glucose
metabolism within the liver, playing a crucial role in maintaining glucose homeostasis in
mammalian bodies and controlling the rates of glycolysis in other tissues1. The
concentration of F-2,6-P2 is regulated by the bifunctional enzyme, 6-phosphofructo-2*
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kinase/fructose-2,6-bisphosphatase (PFKFB). The N-terminal half of the enzyme subunit (6phosphofructo-2-kinase domain) catalyzes the synthesis of F-2,6-P2, using fructose-6phosphate (F-6-P) and adenosine 5'-triphosphate (ATP) as substrates (Figure 1A).
Conversely, the C-terminal half (fructose-2,6-bisphosphatase domain) is responsible for the
hydrolytic degradation of F-2,6-P2 into F-6-P and inorganic phosphate (Pi). These two
mutually opposing catalytic activities are controlled by different mechanisms such that
either activity is predominant in a given physiological condition. Ultimately, the PFKFB
control of F-2,6-P2 production/degradation controls the rate of glucose metabolism2.
In order to optimize the regulation of F-2,6-P2 in a tissue-specific manner, there exist four
PFKFB tissue-specific isoforms each encoded by separate genes pfkfb1–4. They are liver,
PFKFB1; heart, PFKFB2; testis, PFKFB4; and inducible forms, PFKFB33; 4; 5; 6. These
isoforms share highly conserved core catalytic domains (85%)(Figure 2), but differ greatly
in their kinetic properties and responses to regulatory signals. These differences are mostly
due to highly divergent N- and C-terminal regulatory domains7; 8; 9; however, a few but
significant sequence differences in the catalytic domains that constitute the secondary
residue shells surrounding the active sites also contribute to the kinetic differences10.
Differences in the structure/function relationships between these isoforms have been
addressed using the available crystal structures of PFKFB1, PFKFB3, and PFKFB411; 12; 13.
For a more complete comparison, the structure of PFKFB2 needs to be determined.
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Unlike the other isoforms, PFKFB3 is ubiquitously expressed upon the onset of
hypoxia14; 15 and has been shown to be identical to the isoforms isolated from placenta,
pancreatic β-islet, and brain10; 16; 17. PFKFB3 has a uniquely large 6-phosphofructo-2kinase to fructose-2,6-bisphosphatase activity ratio compared to other isoforms. This
isoform, which has a native activity ratio of roughly 700 fold kinase-to-phosphatase activity,
dramatically increases up to 3000 upon phosphorylation of Ser460 by protein kinase A
(PKA) or AMP-dependent protein kinase (AMPPK)18; 19; 20; 21; 22. Recent studies suggest
that this form is a causative molecule of highly elevated levels glycolysis in tumor cells, a
phenomenon known as the `Warburg effect'23. Thus, it has also been suggested that
PFKFB3 may serve as a promising new target for future cancer chemotherapy24; 25.
Consequently, an intensive study to investigate the structure/function relationship of
PFKFB3 has been performed, and the catalytic mechanism of the kinase reaction for the
synthesis of F-2,6-P2 was recently hypothesized from the structural evidence11; 26.
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The low bisphosphatase activity of PFKFB3, which is lower than that of other isoforms by
an order of magnitude19, provides a unique opportunity for the study of the bisphosphatase
reaction. In the present study, we determined an improved crystal structure of the PFKFB3
phospho-enzyme intermediate state (PFKFB3-P•F-6-P) trapped during the bisphosphatase
reaction; PFKFB3 complexed with aluminum tetrafluoride (AlF4) within the bisphosphatase
catalytic pocket (PFKFB3•AlF4), which mimics the transition state of a phosphoryl transfer;
and PFKFB3 complexed with inorganic pyrophosphate (PFKFB3•PPi) in which a novel
conformation of C-terminus residues 440–446 was observed. From these structures, we were
able to deduce all the structures necessary for understanding of this reaction, namely, the
Michaelis complex state and the transition states. This study provided a new insight into the
catalytic mechanism of this histidine phosphatase and the results are discussed here.

Results
Overall Structure
In this study, three models (PFKFB3-P•F-6-P, PFKFB3•AlF4, and PFKFB3•PPi) which in
concert detail the enzyme state through substrate binding, catalysis, and product release
during the bisphosphatase reaction (Schematic 1) are being introduced. The global
Proteins. Author manuscript; available in PMC 2013 April 1.
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conformation of these models including crystal contacts, the dimeric interface, and domain/
domain interactions are not significantly affected by the liganding conditions varied in this
experiment. As detailed in previous structural studies, a subunit of the active dimer of
PFKFB3 is comprised of a single polypeptide encompassing two catalytic domains. (Figure
1A) In each complex, N-terminal residues 4 through 15 form a β-hairpin structure to make
contacts with bisphosphatase domain at the area where the residues involved in binding of
both product and substrate are concentrated. In this way, the self-regulatory effect of the Nterminus on F-2,6-P2ase activity11 is not affected by experimentally varied liganding. Unlike
the N-terminus, the C-terminus residues (460–520) remain disordered and have not yet been
elucidated. The only apparent conformational change observed occurs at C-terminus
residues 440–446 and is explained in detail in later sections of this article.
PFKFB3-P•F-6-P Structure
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The electron densities of the crystals soaked with F-2,6-P2 show F-2,6-P2 to be
dephosphorylated to F-6-P within the catalytic pocket of the bisphosphatase domain. The
phosphate transferred from O2 of F-2,6-P2 was covalently bound to NE2 of His253 with a
distance of 1.7Å in a covalent phospho-enzyme intermediate state (PFKFB3-P•F-6-P). The
distance between the His-P phosphorous and O2 of F-6-P, the leaving group, is 3.4Å. The
oxygens of the His-P phosphate make numerous interactions with the protein residues such
that the E-P state is stabilized. The residues involved in the interactions with the E-P
phosphate are Arg252, His387, and Asn259. The details of these interactions are described
in following sections, and they are summarized in Table I. The improved PFKFB3-P•F-6-P
model described here is an extension of resolution and confirms the orientation previously
described by PDB ID:2I1V26. A similar model of PFKFB in the E-P•F-6-P intermediate
state has been previously described using the rat liver isoform (RL2K) of PFKFB27.
Unfortunately, conclusions regarding the human PFKFB3 should be drawn cautiously from
the RL2K model, as this was a truncated form, which lacked the kinase domain and thirty
residues of the C-terminus. As a result, the bound F-6-P was found near the interface of two
protein molecules within the crystal lattice, and the water-bridged interactions between the
analogous Thr440 and F-6-P, whose importance is described in later sections, was lost.
These circumstances resulted in a notably different position of F-6-P27; 28.
PFKFB3•AlF4 structure
A crystal soaked with NaF and AlCl3 shows an electron density representing a square planar
AlF4 within the catalytic pocket of the PFKFB3 bisphosphatase domain (Figure 3A). The
metal makes two collinear axial bonds to NE2 of His253 and to the oxygen of a water
molecule, each with the distance of 2.1Å and 1.9Å, respectively.
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As shown in Figure 3A, F3 interacts with His387, F4 with Asn259 and Arg252, and F2 with
Arg252. F1 of AlF4 makes a unique short-range interaction with Asn256. Geometric details
of the interactions are provided in Table I. Consequently, the atoms of bound AlF4, together
with the apical water and NE2 of His253 constitute, a tetragonal bipyramidal structure,
which seems to mimic a trigonal bipyramidal phosphorane structure that is transiently
formed during the phosphoryl transfer reaction. The apical water molecule also makes a
short-range, 2.8Å, interaction with Glu322. This finding strongly suggests the function of
Glu322 is to neutralize the leaving group and to activate the attacking water molecule.
The PFKFB3•AlF4 structure is the first PFKFB3 model described in which the product of
the phosphatase domain, F-6-P, is absent. It is also the first structure in which the invariant
region (residues 440–446), whose amino acid sequence and conformation is strongly
conserved among all four PFKFB isoforms, is disordered (Figure 3B). Details regarding this
particular conformational change will be discussed in the following sections.
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The crystal soaked with pyrophosphate and F-6-P showed electron density representing
pyrophosphate (PPi) within the bisphosphatase site (Figure 4A), while the kinase site was
occupied by two pyrophosphate molecules (data not shown). Within the bisphosphatase
domain, the second phosphorous of the pyrophosphate and its conjugate oxygens have a
lower occupancy. The high occupancy phosphorus atom is 3.5Å from His253. Although it
was included in the soaking solution, F-6-P is absent from the bisphosphatase active site,
suggesting that the E•Pi•F-6-P complex is not favored. This model can be taken as a
representative of the E•Pi state.
Residues 440–446, which were interpreted as a random coil in all models before the
PFKFB3•AlF4 structure, in which it was disordered (Figure 4C), can now be seen as a weak,
continuous density which was interpreted as an α-helix extending outward from the active
site (Figure 4C).
Comparison of Bisphosphatase Active Sites
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Three models are described above (PFKFB3-P•F-6-P, PFKFB3•AlF4, and PFKFB3•PPi).
Within each of these three models, a representation of the transferred 2-phosphate (His-P,
AlF4, and PPi, respectively), each at a various stage of the catalytic reaction (E-P•F-6-P, EP-F-6-P/E-P-H2O transition states, and E•Pi, respectively), can be extracted. Within each of
these representations, the represented oxygens of the transferred 2-phosphate maintain
interactions with His387, Asn259, and Arg252 (Table I). Therefore, these residue sidechains must remain in contact with the 2-phosphate oxygens throughout the reaction.
Glu322 makes interactions with the O2 of F-6-P in the PFKFB3-P•F-6-P model, with the
apical water of the bipyramid within the PFKFB3•AlF4 model, and with the O1 of high
occupancy phosphate of PPi within the PFKFB3•PPi model (Table I). The significance of
this will be explained in later sections.
The O1 oxygen of the high occupancy phosphate of PPi within the PFKFB3•PPi model is at
the approximately same position as the O2 of F-6-P within the PFKFB3-P•F-6-P model. The
summation of the atoms within these two molecules yields a representation of the
bisphosphatase substrate F-2,6-P2 (Figure 5A), allowing a hypothetical model of the
Michaelis complex (Figure 5B).
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Because of the absence of F-6-P within the PFKFB3•PPi model, two waters, which bridge
extensive interactions between F-6-P and the C-terminus in the PFKFB3-P•F-6-P model, are
lost. The Cα of Thr440 moves 2.5Å out of the active site, and the side-chain rotates 113–
132° outward from the active site. Simultaneously, His441 acts to replace Arg442 in a πCation interaction with Tyr333. The displacement of Arg442 allows coiling of the newly
observed α-helix (Figure 4B).
Degradation of Fructose-2,6-Bisphosphate
Based on the three structures, a molecular model of the F-2,6-P2ase reaction of the human
inducible form of PFKFB is suggested. This mechanism is in direct agreement with the
mechanism suggested for the human testes form of PFKFB28. The models introduced in this
work, in particular PFKFB3•AlF4, increase confidence in assumptions concerning the
mechanism of PFKFB3 by offering structural details that were not previously available in
any isoform.
Binding of Substrate (E → E•F-2,6-P2)—In Figure 5B, the F-2,6-P2 representation
summed from the high occupancy phosphate of the PFKFB3•PPi model and the F-6-P of the
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PFKFB3-P•F-6-P model confirms that the 6-phosphate moiety is recognized by Arg347,
Lys351, and Tyr362 and that the 2-phosphate moiety is recognized by residues His387,
Asn259, and Arg252. The C-terminal residues 440–446 are stabilized as a random coil
through water-mediated interactions with F-2,6-P2.
Formation of the Phospho-Enzyme Intermediate (E•F-2,6-P2 → E-P•F-6-P)—In
Figure 5C, the three newly introduced models allow us to observe three positions of the 2phosphate during the phosphoryl transfer; PPi, AlF4, and His-P. By tracking through all
three representations of the phosphorous of 2-phosphate (His-P, AlF4, PPi), a nearly straight
line punctuated at the ends by the NE2 of His253 and the O2 of F-6-P can be seen,
suggesting an “inline” transfer mechanism2. This supports the direct inversion of oxygen
stereochemistry through the PFKFB3-P•F-6-P to PFKFB3•PPi models with the transition
state represented by the equatorial plane formed by the peripheral fluorines of AlF4. An
equatorial plane created by the migrating peripheral oxygens of phosphate was
hypothesized28, but never before has it been so clearly depicted. Note that the arrangement
of AlF4, bound by PFKFB3, cannot exactly mimic the trigonal bipyramidal transition state
of the phosphoryl-transfer reaction but is considered an adequate approximation in
phosphoryl-transfer mechanisms29; 30; 31; 32; 33.
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Upon binding of F-2,6-P2, the NE2 of His253 is in position for a nucleophilic attack on the
2-phosphate. This attack is aided by the interactions of 2-phosphate with Arg252, His387,
and Asn259. The resulting interactions would stabilize the transition state by delocalizing
the electrons in the 2-phosphate towards the side-chains of residues Arg252, His387, and
Asn259 making the phosphorous of the 2-phosphate more electrophilic. This would enhance
the nucleophilic attack of the lone pair of electrons of the NE2 of His253. The removal of 2phosphate from F-2,6-P2 would leave a highly basic anion that would need to be neutralized
to prevent reformation of the reaction substrates. The general proximity of Glu322 suggests
that it is positioned to function as the general acid and donates a proton to the leaving O2
after His-P formation. This is consistent with kinetic studies of the conserved Glu327 within
the rat liver isoform, which suggests that Glu327 acts as both a general acid during the E-P
formation and a general base during E-P breakdown2; 34. The reaction mechanism resulting
in the E-P•F-6-P intermediate is summarized in Schematic 2.

NIH-PA Author Manuscript

Release of F-6-P and Degradation of the Phospho-Histidine Intermediate (EP•F-6-P → E-P → E•Pi)—Upon the departure of the F-6-P and the two waters which
bridge interactions between F-6-P and residues 440–446, this segment of the C-terminus is
no longer stabilized as a random coil. A molecule of water would then move in to the apex
of a tetragonal bipyramidal configuration and the mechanism by which E-P would
breakdown is presumably the reverse of its formation. Glu322 would withdraw a hydrogen
from the water and the resulting strong anion would attack the electrophilic phosphate while
the transition state is stabilized by residues Arg252, His387, and Asn259 (Schematic 2). The
importance of the water found at the apex of the bipyramid now becomes immediately
apparent. The activation of water by Glu322 has been hypothesized2; 28; 34, but the
placement of a water molecule in a position of attack has never before been depicted. The
track of the peripheral oxygens through the equatorial transition state during the formation
of free phosphate is also represented by the PFKFB3•AlF4 model. In actuality, because of
the absence of F-6-P in the PFKFB3•AlF4 model, the track of the peripheral oxygens during
the phospho-histidine breakdown is more directly portrayed than the formation of the
phospho-histidine. Upon the formation of the free phosphate, residues 440–446 shift away
from the active site and appear to coil into an α-helix.
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The three models introduced in this article provide a clearer understanding of the
bisphosphatase reaction of the inducible form of the bifunctional enzyme by both supporting
previous assumptions derived from other isoforms, and distinguishing unique characteristics
of this particular polypeptide. The PFKFB3-P•F-6-P model allows confirmation of the
positioning of the fructose and 6-phosphate atoms as well as the residues responsible for
their binding, whereas the PFKFB3•PPi does the same for the atoms of the 2-phosphate. The
PFKFB3•AlF4 model directly illustrates the stereochemistry of the bisphosphatase reaction
for the first time amongst all isoforms.
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It has been suggested that the reduced bisphosphatase activity of PFKFB3 is solely due to
the presence of a serine at residue 302 instead of an arginine as conserved in the other
isoforms (Figure 2). This residue is said to interact with the 2-phosphate and further
stabilizes the transitions state, if conserved11; 12; 13. Studies have reported that the
restoration of this serine to arginine rescues the ability to generate and degrade the His-P
intermediate19. Strangely, however, despite not a having arginine at position 302, PFKFB3
has the ability to form the phospho-histidine intermediate but merely lacks the ability to
degrade it. This article provides structural evidence of a conformational change in Cterminal residues 440–446 and suggests that the reason for the depressed bisphosphatase
activity may be more complex than simply a single mutated residue. The absence of F-6-P
from the active site causes rearrangement of the C-terminus residues 440–446. Perhaps, this
is suggestive that bisphosphatase activity is further regulated through the control of ligand
binding and product release, or perhaps the degradation of the active site after the release of
F-6-P.
It should be noted that the pivotal residues of this conformational change (Thr440, His441,
Arg442) are absolutely conserved across all known mammalian isoforms of fructose-2,6bisphosphatase. In addition, previous works with the rat liver isoform, which was truncated
just before the Thr-His-Arg segment, resulted in a nine-fold increase in kcat, an eleven-fold
increase in Km, and relief of pH dependent regulation of bisphosphatase activity9.
No similar conformation change in residues 440–446 has been seen in any other isoforms
(Figure 1B), yet additional studies are needed to conclusively ensure that this phenomenon
is unquestionably unique to PFKFB3. However, from our research, we are confident that the
π-cation interaction between Arg442 and Tyr333 is unique to PFKFB3 among all currently
known isoforms. In both PFKFB1 and PFKFB4 models, this conserved arginine forms a salt
bridge with an aspartic acid, namely Asp353 and Asp351, respectively. Arg442 does not
interact with a glutamic acid, Glu348, at this same position within PFKFB3(Figure 2).
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Materials and Methods
Preparation and crystallization of PFKFB3
Protein preparation and crystallization was similar to methods previously described11; 26.
The His6-tagged human inducible isoform of the bifunctional enzyme, PFKFB3, was
expressed in Escherichia coli BL21 (DE3) pLysS and was purified by Ni-NTA affinity
columns. The protein sample was further purified using Q-sepharose anion-exchange
chromatography. This purified protein was kept at a concentration of 8 mg ml−1 in pH 8.0,
20 mM Tris-HCl, 10 mM NaxPi, 5 mM β-mercaptoethanol, and 5% glycerol. Crystal were
grown using sitting drop vapor diffusion with a 1:1 (v/v) mixture of protein with a mother
liquor of 100 mM Tris-HCl, pH 7.5, 20–25% ethylene glycol, 200–400mM Tartaric Acid,
5% glycerol, and 12% polyethylene glycol 4000. Crystals in a size of 0.2 × 0.2 × 0.05 mm
were grown in two to three weeks.
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The crystals were soaked with cryoprotectant solutions for 0.5 to 2 hours to allow binding of
the desired ligands. Cryoprotectant solutions consisted of 20 mM Tris-HCl pH 7.5 buffer
and 12% polyethylene glycol 4000, and were enriched with 35% ethylene glycol and the
targeted ligands. The PFKFB3-P•F-6-P crystal was soaked with 3mM ADP 0.5mM F-2,6P2. The PFKFB3•AlF4 crystal was soaked with 3mM ADP, 0.5mM F-6-P, 2mM AlCl3, and
8mM NaF. The PFKFB3•PPi crystal was soaked with 3mM PPi. The soaked crystals were
flash cooled at 100K and the temperature was maintained during data collection using an
Oxford cryo device.
Data Collection and Processing
Diffraction data for the PFKFB3•AlF4 and the PFKFB3-P•F-6-P crystals was collected at
The Gulf Coast Consortium Protein Crystallography Beamline (PX1) in The Center for
Advanced Microstructures and Devices (CAMD), Louisiana State University, Baton Rouge,
LA using a x-ray source wavelength of 1.3808Å the data was recorded on a Mar 165mm
CCD detector and was integrated, merged, and scaled using HKL200035.
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Diffraction data for the PFKFB3•PPi crystal was collected at The Northeastern
Collaborative Access Team (NE-CAT) beamline at the Advanced Photon Source (Argonne
National Laboratory) using an x-ray source wavelength of 0.9792Å. The data was recorded
on an ADSC Q315 (315mm × 315mm) detector and was integrated, merged, and scaled
using HKL200035. Statistics of the diffraction data and structure refinement are summarized
in Table II. All crystals belonged to the P6522 space group, and the cell dimensions were
similar.
Structure Determination and Refinement
The reduced data was formatted for the program suite of CCP436; 37 and 5% of the data was
marked for free R-factor measurements in subsequent structure refinements. Initial models
of all complexes were determined using REFMAC38 within the CCP4 suite with the
PFKFB3•ADP•EDTA complex (PDB ID: 2AXN11) as the starting molecule after removal of
the ligand and solvent molecules. The initial model went through many cycles of manual
model rebuilding and validation using the program COOT39. Binding of the ligands was
confirmed, referring to the |Fo| -|Fc| omit maps that were generated, when Rcrys/Rfree
reached 0.25/0.28 or below and the ligands were incorporated into the complex models.
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As summarized in Table II, the PFKFB3-P•F-6-P complex has Rfree/Rcrys of 0.247/0.193
using a total of 3,849 scatterers, including solvent molecules, against all 30,381 available
reflections in the resolution range of 30.0–2.45Å. The structure contains a total of 441 amino
acid residues of the full-length protein of 520 residues. As in the PFKFB3•ADP•EDTA
complex, the C-terminus (residues 446–520) is mostly disordered.
The final structure of the PFKFB3•AlF4 complex has Rfree/Rcrys of 0.242/0.200 using a total
of 3,837 scatterers, including solvent molecules, against all 38,530 available reflections in
the resolution range of 30.0–2.25Å. The structure contains a total of 431 amino acid residues
of the full length protein of 520 residues.
The final structure of the PFKFB3•PPi complex has Rfree/Rcrys of 0.236/0.184 using a total
of 3,959 scatterers, including solvent molecules, against all 36,888 available reflections in
the resolution range of 35.0–2.30Å. The structure contains a total of 439 amino acid residues
of the full-length protein, which consists of 520 residues.
The atomic coordinates and structure factors of the PFKFB3-P•F-6-P complex (PDB ID:
3QPV), the PFKFB3•AlF4 complex (PDB ID: 3QPW), and the PFKFB3•PPi complex
(PDB ID: 3QPU) have been deposited in the RCSB Protein Data Bank.
Proteins. Author manuscript; available in PMC 2013 April 1.
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PFKFB

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase

6-PF-2-K

6-phosphofructo-2-kinase

F-2,6-P2ase

fructose-2,6-bisphosphatase

PFK-1

6-phosphofructose-1-kinase

F-1,6-P2ase

fructose-1,6-bisphosphatase

F-2,6-P2

fructose-2,6-bisphosphate

F-6-P

fructose-6-phosphate

ATP

adenosine 5'-triphosphate

Pi

orthophosphate

PPi

pyrophosphate

PKA

protein kinase A

AMPPK

AMP-dependent protein kinase

AlF4

aluminum tetrafluoride
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Figure 1. Overall folding of PFKFB3 and sites of ligand binding
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All figures, unless otherwise noted, were constructed using PyMOL (The PyMOL Molecular
Graphics System, Version 1.2r3pre, Schrödinger, LLC.). (A) The overall fold of the
monomeric PFKFB3 is represented in a ribbon diagram. The N-terminal kinase domain (6PF-2-k) is shaded red while the C-terminal bisphosphatase domain (F-2,6-P2ase) is shaded
blue. Each active site location can be discerned by the bound ligands. The ADP and F-2,6-P2
are within the kinase active site while F-6-P and a covalently attached phosphate are within
the bisphosphatase active site. Molecules of interest are represented in stick models. (B) To
compare the organization of the C-termini, the bisphosphatase domains of the inducible
(blue) (PDB ID: 2AXN), testes (yellow) (PDB ID: 1BIF), and liver (red) (PDB ID:
1K6M)8,9,10 isoforms have been superimposed. The folding patterns are represented by a
tracing of the C-alphas.
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Figure 2. Sequence alignment of PFKFB

Shown are the sequence alignments of the bisphosphatase domain of the four PFKFB
isoforms. Residue numbering coincides with the residues of PFKFB3. Residues involved in
catalysis, substrate binding, and the initiation of the conformational change are emphasized
with boxes. Asterisks mark residues of interest that are conserved in all isoforms except for
PFKFB3.
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Figure 3. Aluminum tetrafluoride within the active site

(A) A stereo view within the bisphosphatase active site of the PFKFB3•AlF4 model is
shown. The mesh represents the |Fo| -|Fc| electron density omit map of aluminum
tetrafluoride and a bound water molecule within the bisphosphatase active site. The map is
contoured at 3.0σ levels. Arg252, Asn259, and His387 interact with the peripheral fluorines
of aluminum tetrafluoride. Glu322 interacts with a water at the apex of the bipyramidal
structure. The aluminum atom is situated 1.9Å from the water and 2.1Å from His253. The
dotted lines mark significant interactions. Molecules/residues of interest are represented in
stick models. (B) Shown is a ribbon representation in stereo view of the overlapping
bisphosphatase active sites of the PFKFB3-P•F-6-P(green) and PFKFB3•AlF4(yellow)
models. C-terminal residues 440–446 of the PFKFB3•AlF4 model can no longer be tracked.
Spheres represent the positions of the C-alphas of the missing residues as projected from the
PFKFB3-P•F-6-P model.
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Figure 4. Pyrophosphate within the active site
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(A) A stereo view within the bisphosphatase active site of the PFKFB3•PPi model is
shown. The mesh represents the |Fo| -|Fc| electron density omit map of PPi within the
bisphosphatase active site. The map is contoured at 3.0σ levels. Arg252, Asn259, and
His387 interact with the pyrophosphate oxygens that are assumed to be at the positions of
the 2-phosphate oxygens of F-2,6-P2. The phosphorous is situated 3.5Å from His235. The
dotted lines mark significant interactions. Molecules/residues of interest are represented in
stick models. (B) Ribbon representations in stereo of the overlapping models of PFKFB3P•F-6-P (green) and PFKFB3•PPi (magenta) are shown. Molecules/residues of interest are
represented in stick models. Upon the absence of F-6-P, two waters which bridge
interactions with the C-terminal segment covering the active site are lost. The C-terminal
residues 440–446 are no longer seen as a random coil extending over the bisphosphatase
active site, but as a helix extending outwards away from the active site. After the loss of the
two water bridged interactions, Thr440 rotates out of the active site. Simultaneously, His441
replaces Arg442 in a π-cation interaction with Tyr333. Arg442 can then commence the
coiling of the observed helix. (C) Shown are the C-terminal residues of the PFKFB3•PPi
model. Residues 425–436 are represented as a ribbon while residues 437–446 are
represented with sticks. The mesh represents the |Fo| -|Fc| electron density omit map of Cterminal residues 437–446 of the bisphosphatase active site. The map is contoured at 2.0σ
levels.
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Figure 5. A hypothetical representation of the Michaelis complex (E•F-2,6-P2)
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Here is the Michaelis complex as constructed using ligands from the PFKFB3-P•F-6-P and
PFKFB3•PPi models. Molecules/residues of interest are represented in stick models. (A) A
stereo view of the overlapping bisphosphatase active sites of both the PFKFB3-P•F-6P(green) and PFKFB3•PPi(magenta) models is shown. The pyrophosphate of the
PFKFB3•PPi model and the F-6-P of the PFKFB3-P•F-6-P model have been included but
not the covalently bound phosphate. The lower occupancy phosphoryl group of PPi has been
grayed. The remaining ligand atoms can be used to construct a continuous representation of
bound F-2,6-P2. (B) A complete representation of the Michaelis complex projection is
shown in pink. The 2-phosphate moiety is recognized by residues Arg252, Asn259, and
His387. The 6-phosphate moiety is recognized by residues Arg347, Lys351, and Tyr362.
(C) The ligands from all three models are displayed. The lower occupancy phosphoryl group
of PPi has been grayed. The direct inversion of oxygen stereochemistry, through the
E•F-2,6-P2 to E-P states with the transition state represented by the equatorial plane formed
by the peripheral fluorines of AlF4, can be tracked. By tracking through all three
representations of the 2-phosphate phosphorous (His-P, AlF4, PPi), one would create an
approximately straight line punctuated at the ends by the NE2 of His253 and the O2 of F-6P.
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Schematic 1. Schematic 1. The minimal enzymatic reaction

The various enzyme states of PFKFB3 through a minimal enzymatic reaction are shown:
free enzyme (E), the Michaelis complex (E•F-2,6-P2), phospho-enzyme intermediate (EP•F-6-P), and the states of product release (E-P, E•Pi).
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Schematic 2. The complete mechanism of phospho-histidine formation/degradation
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This schematic was prepared with ChemBioDraw (ChemBioDraw Ultra 10.0
CambridgeSoft, 100 CambridgePark Drive, Cambridge, MA 02140). Brackets indicate a
transition state in which a direct inversion of phosphate stereochemistry occurs. Upon
binding of F-2,6-P2, His253 is in position for a nucleophilic attack on the 2-phosphate.
Interactions with Arg252, His387, and Asn259 stabilize the transition state by delocalizing
the electrons towards the residues making the P of 2-phosphate more electrophilic. This
enhances the nucleophilic attack of the lone pair of electrons of the NE2 of His253. Glu322
acts as a general acid and donates a proton to neutralize the highly basic anion on the first
product. Glu322 would then withdraw a hydrogen from a water, and this strong anion would
attack the electrophilic phosphate while the transition state is stabilized by residues Arg-252,
His-387, and Asn-259 creating the second product.
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NH1
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Indicates a covalent bond.
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Values in parentheses are distances given in angstroms.
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Notable interactions between the bisphosphatase active site ligands and the protein.
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Statistics of reflection data and structure refinements.
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Liganding

PFKFB3•AlF4

PFKFB3-P•F-6-P

PFKFB3•PPi

Space group

P6522

P6522

P6522

Unit cell dimension (Å)

102.71 × 102.71 × 257.04

102.15 × 102.15 × 259.44

102.98 × 102.98 × 258.13

Wilson Plot B Value (Å2)

45.7

55.6

41.2

Resolution range (Å)

30.0 – 2.25

30.0 – 2.45

35–2.30

Reflections Observed

351,069

434,030

927,757

Unique Reflections

38,530

30,381

36,888

Reflections Rfree set

1,951

5,839

1,975

Completeness (%)

99.5 (98.5)

99.6 (98.7)

100 (99.9)

Redundancy

4.7 (4.6)

5.8 (5.7)

7.6 (7.8)

<I/σ>

18.5 (1.8)

14.9 (1.4)

20.0(2.7)

Rsym

0.071 (0.462)

0.092 (0.824)

.078 (0.756)

Rcrys

0.200

0.193

0.184

Rfree

0.242

0.247

0.236

No. of amino acids

431

441

439

No. of protein atoms

3534

3607

3584

No. of hetero atoms

43

67

55

No. of waters

260

175

320

R.M.S.D. bond lengths (Å)

0.022

0.024

0.024

1.8

2.2

2.1

Protein atoms (Å2)

43.8

42.5

31.2

Hetero atoms (Å2)

51.1

36.5

39.7

Water atoms (Å2)

53.2

48.0

40.4

Ramachandran Outliers(%)

0.0

0.2

0.5

Ramachandran Favored(%)

96.3

93.8

97.2

Poor Rotamers (%)

5.4

8.5

5.3

Angles (°)
Mean B factor

Rsym = Σh (Σj|Ihj − <Ih>|/ Σ Ih,j), where h=set of Miller indices, j=set of observations of reflection h, and <Ih>=the mean intensity. R.M.S.D.
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values are deviation from ideal values. Rcrys= Σh∥Fo,h| − |Fc,h∥/ Σh|Fo,h|. Rfree was calculated using 5% of the complete data set excluded from
refinement. The numbers in parentheses represent values from the highest resolution shell (2.33–2.25 Å for E•AlF4 complex, 2.54–2.45 Å for the
E-P•F-6-P complex, and 2.34–2.30 Å for the E•PPi complex).
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